Active · per the CBE, 17 November 2026

AKSA PHARMA

BE0651787243

Rechtspersoon Private limited company 1 establishment

AKSA PHARMA is a pharmacy in Brussel. Private Limited, started on 11 April 2016, 1 establishment.

Araucarialaan 79, 1020 Brussel

Behind the company: RICHARD BONTEMPS.

Active for

10 year, 7 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Negative equity NBB

    More debt than assets in 1 of the last 4 fiscal years.

  • Two loss years in a row NBB

    Negative result in 2024 and 2025.

  • Tight liquidity NBB

    Cash and receivables cover 24 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

AKSA PHARMA from Brussel, company number BE0651787243, closed financial year 2025 with a result of € -220,750 after tax. For that financial year AKSA PHARMA recorded a gross margin of € -84,856 and equity of € -64,128. Compared with financial year 2024, the result moved from € -54,052 to € -220,750. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.

What it is worth Caution

€ -64,128

▼ € 220,750 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -220,750

▼ 308 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 3,901

▲ 178% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -82,728.

People and assets in 2025

Full-time equivalents

1.6

▼ 2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 91,516

▼ 51% vs 2024

€ 57,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

€ 30,000

▼ 70% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 136,017

▼ 21% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 1,299

▼ 98% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year
2022202320242025Change 2024 → 2025
Gross margin € 375,824 € 438,339 € 173,998 € -84,856 ▼ € 258,854
Profit after taxes € 168,430 € 154,530 € -54,052 € -220,750 ▼ € 166,698
Equity € 56,144 € 210,674 € 156,622 € -64,128 ▼ € 220,750
Total debts € 589,133 € 417,135 € 367,641 € 357,903 ▼ 3%
Cash € 119,968 € 49,966 € 1,404 € 3,901 ▲ 178%
Retained profit € 37,544 € 192,074 € 138,022 € -82,728 ▼ € 220,750
Bank debt € 187,421 € 78,589 € 99,703 € 30,000 ▼ 70%
Balance sheet total € 645,277 € 627,809 € 524,262 € 293,776 ▼ 44%
Employees (FTE) 3 3 3.6 1.6 ▼ 2

By gross margin, AKSA PHARMA ranks 24th of 24 companies with main activity “Detailhandel in farmaceutische producten” in Brussel that publish figures (fiscal year 2025).

Key figures of AKSA PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to AKSA PHARMA?

What happened at AKSA PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 220,750. filed late Source: NBB ↗
  • New establishment in Sint-Lambrechts-Woluwe. KBO
  • Incorporation, published in the Gazette. Source: Staatsblad ↗

In short

From € 168,430 profit in 2022 to € 220,750 loss in 2025.

Paid € 80,465 in corporate taxes since 2022.

Best year ever: 2022, with € 168,430 profit.

On average € 48,300 of value added per employee in 2024.

Management

RICHARD BONTEMPS
AKSA PHARMA

Behind AKSA PHARMA is RICHARD BONTEMPS.

Directors

According to the 2025 annual accounts

RICHARD BONTEMPS

Administrator-manager

Establishments

Establishment units

Physical locations of this company

Registered office

Araucarialaan 79

1020 Brussel

2.252.932.292

Woluwedal 70 box 14

1200 Sint-Lambrechts-Woluwe

Active since 14 May 2016

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Brussel

Same main activity (Detailhandel in farmaceutische producten), 27 active companies in Brussel, largest first.

PHARMACIE HOUBA

€ 21.2 million revenue · 2025

Pharmacie Van Moer

€ 737,131 gross margin · 2025

PHARBIOMED

€ 423,562 gross margin · 2025

PHARMACIE SEKKAT-DEWAND

€ 315,552 gross margin · 2025

PHARMACIE MARIE-CHRISTINE

€ 284,279 gross margin · 2025

PHARMACIE DU STUYVENBERGH

€ 278,523 gross margin · 2025

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

Source: Deed ↗
  • BEN SASSI Khemaïs(oprichter) 70%
  • SMET Anne-Marie, Irene, Theophiel(oprichter) 30%

Details

Company number
0651.787.243
VAT number
BE 0651.787.243
Registered office
Araucarialaan 79, 1020 Brussel
Names & denominations
AKSA PHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
11 April 2016
Peppol
Active · Active since 15 Dec 2025
Activities · NACE

Detailhandel in farmaceutische producten

Frequently asked questions

What does AKSA PHARMA do?
AKSA PHARMA is a pharmacy in Brussel. Private Limited, started on 11 April 2016, 1 establishment.
What is the address of AKSA PHARMA?
The registered office of AKSA PHARMA is located at Araucarialaan 79, 1020 Brussel.
Is AKSA PHARMA still active?
Yes. According to the CBE (17 November 2026) AKSA PHARMA is active, legal situation “Normale toestand”, started on 11 April 2016.
Is AKSA PHARMA registered on Peppol?
Yes, AKSA PHARMA is registered on the Peppol network with ID 0208:0651787243.
What is the enterprise number of AKSA PHARMA?
The enterprise number of AKSA PHARMA is BE0651787243.
When was AKSA PHARMA founded?
AKSA PHARMA was founded on 11 April 2016.